InsidersTradesSigma
Discover the detailed record of transactions filed by Giordano Natasha, Chairman & CEO. Officer active across 1 company, notably PLx Pharma Inc.. Aggregated, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. Activity tracked since 15 March 2022. The latest transaction was disclosed on 15 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Natasha Giordano serves as the Chief Executive Officer of PLx Pharma Inc. She is responsible for the strategic direction of the company, overseeing all operations and business initiatives. With extensive experience in the pharmaceutical industry, she plays a key role in developing new products and expanding markets. Her vision and leadership are crucial for the success of PLx Pharma.